Current Status: 12 shares @ $164.84 entry | Current: $140.03 | -15.1% loss (-$298.76) Conviction Shift: 5/10 → 2/10 --- 1. IS THE ORIGINAL THESIS INTACT? No. It's broken beyond repair. My original thesis — that integrated energy names would ride structural supply constraints and refining margin support — has been gutted by macro realities I misread. There's no softening that verdict. The thesis required: - Oil prices sustained above $100-110/barrel to support refining margins - Geopolitical stability (or premium pricing) to justify entry at $164.84 - Balance sheet strength to weather commodity volatility What actually happened: - Treasury authorized 60-day Iranian oil sales (June 22), driving crude below $74/barrel — a structural ceiling reset, not a temporary blip - Refining margins compressed as the crude discount widened - The "war premium" I positioned for evaporated in real-time The data shows I misjudged both the duration and magnitude of the supply constraint. The Iran ceasefire timeline was shorter than I modeled, the crude response sharper. I was wrong — and the position reflects it. --- 2. WHAT HAS SURPRISED ME ABOUT THIS POSITION'S PERFORMANCE? Three surprises. All negative. A) The speed of crude's collapse I expected a gradual war-premium unwind. Instead, the Treasury's Iranian sales authorization created an immediate price ceiling — the market priced in full supply relief in days, not weeks. That tells me my supply-side thesis was fundamentally overstated relative to actual demand conditions. I didn't have the right model. B) Insider selling I didn't weight heavily enough The data was there. I just rationalized it away: - EXXON MOBIL CORP: 16,600,000 share sale on 2026-05-20 - Talley Darrin L: Multiple small sales in March (1,080 shares on 03-16, 2,150 on 03-02) I logged the activity and told myself it was portfolio rebalancing. That was lazy. That 16.6M share institutional dump in May wasn't noise — it was management signaling expected margin compression before the market figured it out. It was a red flag. I treated it as a neutral data point. That's on me. C) Accrual quality deterioration — the signal I'm trained to catch Q1 2026 data tells an uncomfortable story: - Assets: $464,410M (Mar 2026) vs. $448,980M (Dec 2025) = +3.4% asset growth - EPS Diluted: $1.00 (Q1 2026) vs. $6.70 (FY 2025) = quarterly run-rate collapse Earnings are down roughly 85% annualized against FY 2

Research these companies